| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |